Alanna Murday

Alanna Murday is a seasoned professional in corporate strategy and business development, currently serving in that capacity at Affinia Therapeutics since September 2023. Prior to this role, Alanna held a position in corporate strategy at Oncorus from April 2021 to August 2023, and worked in biotechnology equity research at UBS between December 2019 and April 2021. Alanna began a career in consulting at Lumanity (formerly Defined Health and Cello Health BioConsulting) from February 2017 to December 2019. Alanna holds a Doctor of Philosophy (Ph.D.) in Molecular Medicine from the University of Maryland School of Medicine and a Bachelor of Science (BS) in Microbiology and Biochemistry from Rutgers University.